Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by articular and extra-articular manifestations. Among extra-articular involvement, rheumatoid meningitis (RM) is a rare condition, which may exhibit variable symptoms including headache, focal and/or generalized neurologic defi...
Gespeichert in:
| Veröffentlicht in: | Rheumatology international 2021-10, Vol.41 (10), p.1845-1853 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1853 |
|---|---|
| container_issue | 10 |
| container_start_page | 1845 |
| container_title | Rheumatology international |
| container_volume | 41 |
| creator | Yıldırım, Reşit Cansu, Döndü Üsküdar Arık, Deniz Saylısoy, Suzan Korkmaz, Cengiz |
| description | Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by articular and extra-articular manifestations. Among extra-articular involvement, rheumatoid meningitis (RM) is a rare condition, which may exhibit variable symptoms including headache, focal and/or generalized neurologic deficits. It may develop as the preceding manifestation of RA or occur at any time of the disease course. Some drugs used for the treatment of RA may give rise to aseptic meningitis or create a tendency to infectious meningitis due to their immunosuppressive effect. All these possibilities may lead to difficulties in the differential diagnosis. Achieving a diagnosis in a short time is crucial in terms of prognosis. Here, we would like to report a case with longstanding RA manifested by left-sided weakness and seizure shortly after initiating etanercept (ETA) therapy. ETA-induced meningitis was confirmed with appropriate diagnostic tools. Our aim with this case-based review is to attract the attention of this rare condition and discuss diagnostic challenges. |
| doi_str_mv | 10.1007/s00296-021-04822-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2504363547</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2504363547</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-588c78a975e9d7f8ed56d18b1937513b5c74bfa11100ff110b52c64f24e39a823</originalsourceid><addsrcrecordid>eNp9kUtPGzEUha2qqAlp_wCLylI33Rj8GtvDLkLlISHYgNSd5Zm5Q4wynmB7ivj3dRJKJRZsrmX7u-ce3YPQEaPHjFJ9kijltSKUM0Kl4ZyoT2jOpNCEKfr7M5pTpjkxpczQYUqPtNyVol_QTAhdMVbzOVotE2yyb_EAwYcHn33CPuC4gmlwefQddjGv4u7d9RkidiF7cndzjl03-OBTji77MZxih1uXgDSldHjtC-vyFAFH-OPh-Ss66N06wbfXc4Huz3_dnV2S69uLq7PlNWmLp0wqY1ptXK0rqDvdG-gq1THTsHprWTRVq2XTO8bKBvq-1KbirZI9lyBqZ7hYoJ973U0cnyZI2Q4-tbBeuwDjlCyvqBRKVFIX9Mc79HGcYijuCqWkqo0sIxeI76k2jilF6O0m-sHFF8uo3eZg9znYkoPd5WBVafr-Kj01A3RvLf8WXwCxB1L5Cg8Q_8_-QPYvKFGTCg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2564698451</pqid></control><display><type>article</type><title>Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review</title><source>Springer Nature - Complete Springer Journals</source><creator>Yıldırım, Reşit ; Cansu, Döndü Üsküdar ; Arık, Deniz ; Saylısoy, Suzan ; Korkmaz, Cengiz</creator><creatorcontrib>Yıldırım, Reşit ; Cansu, Döndü Üsküdar ; Arık, Deniz ; Saylısoy, Suzan ; Korkmaz, Cengiz</creatorcontrib><description>Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by articular and extra-articular manifestations. Among extra-articular involvement, rheumatoid meningitis (RM) is a rare condition, which may exhibit variable symptoms including headache, focal and/or generalized neurologic deficits. It may develop as the preceding manifestation of RA or occur at any time of the disease course. Some drugs used for the treatment of RA may give rise to aseptic meningitis or create a tendency to infectious meningitis due to their immunosuppressive effect. All these possibilities may lead to difficulties in the differential diagnosis. Achieving a diagnosis in a short time is crucial in terms of prognosis. Here, we would like to report a case with longstanding RA manifested by left-sided weakness and seizure shortly after initiating etanercept (ETA) therapy. ETA-induced meningitis was confirmed with appropriate diagnostic tools. Our aim with this case-based review is to attract the attention of this rare condition and discuss diagnostic challenges.</description><identifier>ISSN: 0172-8172</identifier><identifier>EISSN: 1437-160X</identifier><identifier>DOI: 10.1007/s00296-021-04822-6</identifier><identifier>PMID: 33751192</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Case Based Review ; Medicine ; Medicine & Public Health ; Meningitis ; Rheumatoid arthritis ; Rheumatology</subject><ispartof>Rheumatology international, 2021-10, Vol.41 (10), p.1845-1853</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-588c78a975e9d7f8ed56d18b1937513b5c74bfa11100ff110b52c64f24e39a823</citedby><cites>FETCH-LOGICAL-c375t-588c78a975e9d7f8ed56d18b1937513b5c74bfa11100ff110b52c64f24e39a823</cites><orcidid>0000-0002-1560-964X ; 0000-0003-0905-2731 ; 0000-0003-4040-0212 ; 0000-0001-6543-3905 ; 0000-0003-2679-0699</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00296-021-04822-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00296-021-04822-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33751192$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yıldırım, Reşit</creatorcontrib><creatorcontrib>Cansu, Döndü Üsküdar</creatorcontrib><creatorcontrib>Arık, Deniz</creatorcontrib><creatorcontrib>Saylısoy, Suzan</creatorcontrib><creatorcontrib>Korkmaz, Cengiz</creatorcontrib><title>Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review</title><title>Rheumatology international</title><addtitle>Rheumatol Int</addtitle><addtitle>Rheumatol Int</addtitle><description>Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by articular and extra-articular manifestations. Among extra-articular involvement, rheumatoid meningitis (RM) is a rare condition, which may exhibit variable symptoms including headache, focal and/or generalized neurologic deficits. It may develop as the preceding manifestation of RA or occur at any time of the disease course. Some drugs used for the treatment of RA may give rise to aseptic meningitis or create a tendency to infectious meningitis due to their immunosuppressive effect. All these possibilities may lead to difficulties in the differential diagnosis. Achieving a diagnosis in a short time is crucial in terms of prognosis. Here, we would like to report a case with longstanding RA manifested by left-sided weakness and seizure shortly after initiating etanercept (ETA) therapy. ETA-induced meningitis was confirmed with appropriate diagnostic tools. Our aim with this case-based review is to attract the attention of this rare condition and discuss diagnostic challenges.</description><subject>Case Based Review</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Meningitis</subject><subject>Rheumatoid arthritis</subject><subject>Rheumatology</subject><issn>0172-8172</issn><issn>1437-160X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp9kUtPGzEUha2qqAlp_wCLylI33Rj8GtvDLkLlISHYgNSd5Zm5Q4wynmB7ivj3dRJKJRZsrmX7u-ce3YPQEaPHjFJ9kijltSKUM0Kl4ZyoT2jOpNCEKfr7M5pTpjkxpczQYUqPtNyVol_QTAhdMVbzOVotE2yyb_EAwYcHn33CPuC4gmlwefQddjGv4u7d9RkidiF7cndzjl03-OBTji77MZxih1uXgDSldHjtC-vyFAFH-OPh-Ss66N06wbfXc4Huz3_dnV2S69uLq7PlNWmLp0wqY1ptXK0rqDvdG-gq1THTsHprWTRVq2XTO8bKBvq-1KbirZI9lyBqZ7hYoJ973U0cnyZI2Q4-tbBeuwDjlCyvqBRKVFIX9Mc79HGcYijuCqWkqo0sIxeI76k2jilF6O0m-sHFF8uo3eZg9znYkoPd5WBVafr-Kj01A3RvLf8WXwCxB1L5Cg8Q_8_-QPYvKFGTCg</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Yıldırım, Reşit</creator><creator>Cansu, Döndü Üsküdar</creator><creator>Arık, Deniz</creator><creator>Saylısoy, Suzan</creator><creator>Korkmaz, Cengiz</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1560-964X</orcidid><orcidid>https://orcid.org/0000-0003-0905-2731</orcidid><orcidid>https://orcid.org/0000-0003-4040-0212</orcidid><orcidid>https://orcid.org/0000-0001-6543-3905</orcidid><orcidid>https://orcid.org/0000-0003-2679-0699</orcidid></search><sort><creationdate>20211001</creationdate><title>Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review</title><author>Yıldırım, Reşit ; Cansu, Döndü Üsküdar ; Arık, Deniz ; Saylısoy, Suzan ; Korkmaz, Cengiz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-588c78a975e9d7f8ed56d18b1937513b5c74bfa11100ff110b52c64f24e39a823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Case Based Review</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Meningitis</topic><topic>Rheumatoid arthritis</topic><topic>Rheumatology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yıldırım, Reşit</creatorcontrib><creatorcontrib>Cansu, Döndü Üsküdar</creatorcontrib><creatorcontrib>Arık, Deniz</creatorcontrib><creatorcontrib>Saylısoy, Suzan</creatorcontrib><creatorcontrib>Korkmaz, Cengiz</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Rheumatology international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yıldırım, Reşit</au><au>Cansu, Döndü Üsküdar</au><au>Arık, Deniz</au><au>Saylısoy, Suzan</au><au>Korkmaz, Cengiz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review</atitle><jtitle>Rheumatology international</jtitle><stitle>Rheumatol Int</stitle><addtitle>Rheumatol Int</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>41</volume><issue>10</issue><spage>1845</spage><epage>1853</epage><pages>1845-1853</pages><issn>0172-8172</issn><eissn>1437-160X</eissn><abstract>Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by articular and extra-articular manifestations. Among extra-articular involvement, rheumatoid meningitis (RM) is a rare condition, which may exhibit variable symptoms including headache, focal and/or generalized neurologic deficits. It may develop as the preceding manifestation of RA or occur at any time of the disease course. Some drugs used for the treatment of RA may give rise to aseptic meningitis or create a tendency to infectious meningitis due to their immunosuppressive effect. All these possibilities may lead to difficulties in the differential diagnosis. Achieving a diagnosis in a short time is crucial in terms of prognosis. Here, we would like to report a case with longstanding RA manifested by left-sided weakness and seizure shortly after initiating etanercept (ETA) therapy. ETA-induced meningitis was confirmed with appropriate diagnostic tools. Our aim with this case-based review is to attract the attention of this rare condition and discuss diagnostic challenges.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>33751192</pmid><doi>10.1007/s00296-021-04822-6</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-1560-964X</orcidid><orcidid>https://orcid.org/0000-0003-0905-2731</orcidid><orcidid>https://orcid.org/0000-0003-4040-0212</orcidid><orcidid>https://orcid.org/0000-0001-6543-3905</orcidid><orcidid>https://orcid.org/0000-0003-2679-0699</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0172-8172 |
| ispartof | Rheumatology international, 2021-10, Vol.41 (10), p.1845-1853 |
| issn | 0172-8172 1437-160X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2504363547 |
| source | Springer Nature - Complete Springer Journals |
| subjects | Case Based Review Medicine Medicine & Public Health Meningitis Rheumatoid arthritis Rheumatology |
| title | Aseptic meningitis in rheumatoid arthritis after anti-TNF administration: a case-based literature review |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T03%3A06%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Aseptic%20meningitis%20in%20rheumatoid%20arthritis%20after%20anti-TNF%20administration:%20a%20case-based%20literature%20review&rft.jtitle=Rheumatology%20international&rft.au=Y%C4%B1ld%C4%B1r%C4%B1m,%20Re%C5%9Fit&rft.date=2021-10-01&rft.volume=41&rft.issue=10&rft.spage=1845&rft.epage=1853&rft.pages=1845-1853&rft.issn=0172-8172&rft.eissn=1437-160X&rft_id=info:doi/10.1007/s00296-021-04822-6&rft_dat=%3Cproquest_cross%3E2504363547%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2564698451&rft_id=info:pmid/33751192&rfr_iscdi=true |